These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31822494)

  • 1. Extracellular ATP and Purinergic P2Y
    Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
    Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
    Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
    Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP.
    Xie R; Xu J; Wen G; Jin H; Liu X; Yang Y; Ji B; Jiang Y; Song P; Dong H; Tuo B
    J Biol Chem; 2014 Jul; 289(27):19137-49. PubMed ID: 24847054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the P2Y
    Orriss IR; Guneri D; Hajjawi MOR; Shaw K; Patel JJ; Arnett TR
    J Endocrinol; 2017 Jun; 233(3):341-356. PubMed ID: 28420708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomy.
    Tackett BC; Sun H; Mei Y; Maynard JP; Cheruvu S; Mani A; Hernandez-Garcia A; Vigneswaran N; Karpen SJ; Thevananther S
    Am J Physiol Gastrointest Liver Physiol; 2014 Dec; 307(11):G1073-87. PubMed ID: 25301185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2Y
    Khalafalla FG; Greene S; Khan H; Ilves K; Monsanto MM; Alvarez R; Chavarria M; Nguyen J; Norman B; Dembitsky WP; Sussman MA
    Circ Res; 2017 Nov; 121(11):1224-1236. PubMed ID: 28923792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease.
    Müller T; Fay S; Vieira RP; Karmouty-Quintana H; Cicko S; Ayata K; Zissel G; Goldmann T; Lungarella G; Ferrari D; Di Virgilio F; Robaye B; Boeynaems JM; Blackburn MR; Idzko M
    Oncotarget; 2017 May; 8(22):35962-35972. PubMed ID: 28415591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
    Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
    Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Purinergic Responses Dependent on P2Y2 Receptors in Hepatocytes from CCl
    Velázquez-Miranda E; Molina-Aguilar C; González-Gallardo A; Vázquez-Martínez O; Díaz-Muñoz M; Vázquez-Cuevas FG
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes.
    Thevananther S; Sun H; Li D; Arjunan V; Awad SS; Wyllie S; Zimmerman TL; Goss JA; Karpen SJ
    Hepatology; 2004 Feb; 39(2):393-402. PubMed ID: 14767992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CD39 expression in ATP-P2Y2R-mediated alcoholic liver steatosis and inflammation.
    Liu ZN; Jia WQ; Jiang T; Dai JW; Shuai C; Lv XW
    Int Immunopharmacol; 2019 Dec; 77():105915. PubMed ID: 31639617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2Y
    Jin H; Ko YS; Park SW; Kim HJ
    Free Radic Biol Med; 2019 May; 136():109-117. PubMed ID: 30959169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer.
    Jin H; Ko YS; Kim HJ
    Int J Oncol; 2018 Nov; 53(5):1953-1966. PubMed ID: 30226596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
    Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
    Jin H; Eun SY; Lee JS; Park SW; Lee JH; Chang KC; Kim HJ
    Breast Cancer Res; 2014 Aug; 16(5):R77. PubMed ID: 25156554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Hepatocellular Carcinomas Following Chronic Liver Injury.
    Lin YH; Zhang S; Zhu M; Lu T; Chen K; Wen Z; Wang S; Xiao G; Luo D; Jia Y; Li L; MacConmara M; Hoshida Y; Singal AG; Yopp A; Wang T; Zhu H
    Gastroenterology; 2020 May; 158(6):1698-1712.e14. PubMed ID: 31972235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells.
    Martinez NA; Ayala AM; Martinez M; Martinez-Rivera FJ; Miranda JD; Silva WI
    J Biol Chem; 2016 Jun; 291(23):12208-22. PubMed ID: 27129210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
    Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
    J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma.
    Sheppard S; Guedes J; Mroz A; Zavitsanou AM; Kudo H; Rothery SM; Angelopoulos P; Goldin R; Guerra N
    Nat Commun; 2017 Jan; 8():13930. PubMed ID: 28128200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.